Clinical trial
Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating…
NCT00068341 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00068341 |
|---|---|
| Title | Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer |
| Official title | Neoadjuvant Treatment and Molecular Characterization of Locally Advanced Breast Cancer |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | Aventis Pharmaceuticals Industry Genentech, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | trastuzumab, carboplatin, docetaxel |
| Enrollment | 74 |
| Start date | Jul 1, 2003 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Sep 11, 2003 |
| Last update posted | Sep 9, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: